CC vs IOSP: stock comparison and AI forecast
Chemours Co (CC) and Innospec Inc. (IOSP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CC Chemours Co
- Market Cap
- $1.92B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
IOSP Innospec Inc.
- Market Cap
- $1.95B
- P/E Ratio
- 14.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CC and IOSP have similar market capitalizations ($1.92B and $1.95B).
- IOSP turns 7.4% of its revenue into net income, against -2.9% for CC.
- CC carries 46.05 times debt per unit of equity, against 0.35 times for IOSP.
- CC yields 5.78% in dividends; IOSP pays none.
- Both companies share the SEC industry classification Chemicals & Allied Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CC | IOSP |
|---|---|---|
| Market Cap | $1.92B | $1.95B |
| P/E Ratio | – | 13.98x |
| P/B Ratio | 12.38x | 1.42x |
| Dividend Yield | 5.78% | – |
| EPS | $-0.95 | $5.66 |
| Book Value/Share | $1.03 | $55.74 |
| Revenue/Share | $38.82 | $76.07 |
| FCF/Share | $1.40 | – |
Profitability & Margins
| Metric | CC | IOSP |
|---|---|---|
| ROE | -111.0% | 10.2% |
| ROA | -2.4% | 7.5% |
| ROIC | – | 10.9% |
| Gross Margin | 15.1% | 27.7% |
| Operating Margin | – | 8.8% |
| Net Margin | -2.9% | 7.4% |
| EBT Margin | 2.3% | 9.3% |
| Tax Rate | 228.0% | 19.1% |
Financial Health
| Metric | CC | IOSP |
|---|---|---|
| Current Ratio | 1.81x | 2.95x |
| Quick Ratio | 0.98x | 1.92x |
| D/E Ratio | 46.05x | 0.35x |
| Financial Leverage | 47.05x | 1.35x |
| Interest Coverage | – | 36.8x |
| Working Capital | $1.44B | $683M |
Cash Flow
| Metric | CC | IOSP |
|---|---|---|
| Operating Cash Flow | $400M | $104M |
| Free Cash Flow | $211M | – |
| Capital Spending | -$189M | – |
| OCF Growth YoY | 50.9% | 1.0% |
| FCF/Sales | 3.6% | – |
| CapEx/Sales | 3.2% | – |
Operational Efficiency
| Metric | CC | IOSP |
|---|---|---|
| Asset Turnover | 0.80x | 1.01x |
| Receivables Turnover | 7.6x | 4.7x |
| Inventory Turnover | 3.4x | 3.8x |
| Fixed Assets Turnover | 1.9x | 6.2x |
| Days Sales Outstanding | 48 days | 77 days |
| Days Inventory | 109 days | 97 days |
| Payables Period | 73 days | 44 days |
| Cash Conversion Cycle | 83 days | 130 days |
Income Statement
| Metric | CC | IOSP |
|---|---|---|
| Total Revenue | $5.84B | $1.87B |
| Operating Income | – | $165M |
| Net Income | -$172M | $139M |
| R&D Expense | $104M | $55M |
| SG&A Expense | $855M | $304M |
| Cost of Goods Sold | $4.96B | $1.36B |
Dividend & Shareholder Information
| Metric | CC | IOSP |
|---|---|---|
| Dividends Per Share | $0.74 | – |
| Shares Outstanding | 150M | 25M |
CC vs IOSP: stock comparison and AI forecast
Which is bigger, CC or IOSP?
CC and IOSP have similar market capitalizations ($1.92B and $1.95B).
Which one does Intratio's AI model rank higher, CC or IOSP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.